Terms: = Endocrine gland cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Diagnosis
55 results:
1. Mesonephric-like adenocarcinoma of the ovary.
Yang Y; Zhao M; Jia Q; Tang H; Xing T; Li Y; Tang B; Xu L; Wei W; Zheng H; Shi R; Xia B; Chen J
J Ovarian Res; 2024 Mar; 17(1):57. PubMed ID: 38444000
[TBL] [Abstract] [Full Text] [Related]
2. Invasive micropapillary carcinoma of the breast and bilateral ovarian mature cystic teratoma with benign Brenner tumor in a postmenopausal woman - An uncommon occurrence.
Ayyanar P; Mitra S; Imaduddin M; Muduly DK
Indian J Pathol Microbiol; 2024; 67(1):189-191. PubMed ID: 38358219
[TBL] [Abstract] [Full Text] [Related]
3. Fine needle aspiration biopsy of parathyroid; is it meaningful? A cytologic study of 81 cases with histological and clinical correlations.
Bakuła-Zalewska E; Długosińska J; Stanek-Widera A; Góralski P; Gałczyński J; Żyłka A; Durzyńska M; Dedecjus M
Cytopathology; 2024 May; 35(3):362-370. PubMed ID: 38213192
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of gata3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation.
Ricci C; Ambrosi F; Grillini A; Massari F; Fiorentino M; Colecchia M; Ulbright TM; Acosta AM
Virchows Arch; 2024 Apr; 484(4):709-713. PubMed ID: 38141134
[TBL] [Abstract] [Full Text] [Related]
5. Liver Mass as First-Time diagnosis of Sarcomatoid Anaplastic Thyroid Carcinoma: A Rare Malignancy Presenting at an Unexpected Body Site.
Kamashki A; Rivera M; Sturgis CD
Am J Case Rep; 2023 Dec; 24():e941838. PubMed ID: 38041397
[TBL] [Abstract] [Full Text] [Related]
6. Divergent Lineage Markers in Anaplastic Thyroid Carcinoma.
Mneimneh WS; Asa SL
Am J Surg Pathol; 2024 Feb; 48(2):230-237. PubMed ID: 37972932
[TBL] [Abstract] [Full Text] [Related]
7. HepPar1 and GATA-3 Expression in Neuroendocrine Neoplasms: A Potential Trap for Pathologic diagnosis.
Xu L; Yu G; Jiang L; Song X; Qu G; Luo J; Cai L
Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):668-672. PubMed ID: 37751245
[TBL] [Abstract] [Full Text] [Related]
8. Immunohistochemical and ultrastructural review of six cases previously diagnosed as null cell PitNETs.
Inoshita N; Yoshimoto T; Takazawa Y; Fukuhara N; Okada M; Nishioka H; Yamada S
Brain Tumor Pathol; 2023 Jul; 40(3):158-162. PubMed ID: 37072666
[TBL] [Abstract] [Full Text] [Related]
9. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
10. Malignant testicular unclassified sex cord stromal tumor: a case report.
Morinaga S; Aoki S; Tsuzuki T; Kanematsu K; Kawai N; Sato S; Nakamizu K; Goto K; Niwa M; Nomura I; Sawada T; Futamachi R; Morita F; Yamada Y
J Med Case Rep; 2022 Nov; 16(1):406. PubMed ID: 36335378
[TBL] [Abstract] [Full Text] [Related]
11. An exceptionally rare case of metastatic high-grade urothelial carcinoma of the renal pelvis to the pancreas diagnosed on endoscopic ultrasound-guided fine-needle aspiration: A diagnostic challenge.
Koyuncuer A; Sayar S; Zemheri IE; Özdil K; Özçelik M
Diagn Cytopathol; 2022 Oct; 50(10):E295-E300. PubMed ID: 35656642
[TBL] [Abstract] [Full Text] [Related]
12. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.
Mete O; Wenig BM
Head Neck Pathol; 2022 Mar; 16(1):123-142. PubMed ID: 35312985
[TBL] [Abstract] [Full Text] [Related]
13. Overview of the 2022 WHO Classification of Pituitary Tumors.
Asa SL; Mete O; Perry A; Osamura RY
Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028
[TBL] [Abstract] [Full Text] [Related]
14. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
15. Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials-a case report.
Kaur K; Shah A; Gandhi J; Trivedi P
J Egypt Natl Canc Inst; 2022 Feb; 34(1):9. PubMed ID: 35224708
[TBL] [Abstract] [Full Text] [Related]
16. Role of gata3 in tumor diagnosis: A review.
Khazaeli Najafabadi M; Mirzaeian E; Memar Montazerin S; Tavangar AR; Tabary M; Tavangar SM
Pathol Res Pract; 2021 Oct; 226():153611. PubMed ID: 34547599
[TBL] [Abstract] [Full Text] [Related]
17. Towards a New, Endophenotype-Based Strategy for Pathogenicity Prediction in BRCA1 and BRCA2: In Silico Modeling of the Outcome of hdr/SGE Assays for Missense Variants.
Özkan S; Padilla N; de la Cruz X
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207612
[TBL] [Abstract] [Full Text] [Related]
18. The diagnostic utility of INSM1 and gata3 in discriminating problematic medullary thyroid carcinoma, thyroid and parathyroid lesions.
Adel Hakim S; Mohamed Abd Raboh N
Pol J Pathol; 2021; 72(1):11-22. PubMed ID: 34060284
[TBL] [Abstract] [Full Text] [Related]
19. Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics.
Chang CM; Li YF; Lin HC; Lu KH; Lin TW; Liu LC; Su KM; Chang CC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921111
[TBL] [Abstract] [Full Text] [Related]
20. Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report.
Maeshima Y; Osako T; Morizono H; Yunokawa M; Miyagi Y; Kikuchi M; Ueno T; Ohno S; Akiyama F
J Med Case Rep; 2021 Feb; 15(1):78. PubMed ID: 33593410
[TBL] [Abstract] [Full Text] [Related]
[Next]